Differentiating MYCN-amplified RB1 wild-type retinoblastoma from biallelic RB1 mutant retinoblastoma using MR-based radiomics: a retrospective multicenter case-control study.

Humans Retinoblastoma / genetics N-Myc Proto-Oncogene Protein / genetics Female Magnetic Resonance Imaging / methods Case-Control Studies Male Retrospective Studies Retinoblastoma Binding Proteins / genetics Ubiquitin-Protein Ligases / genetics Child, Preschool Infant Retinal Neoplasms / genetics Machine Learning Mutation Diagnosis, Differential Child Radiomics

MYCN-amplification MRI; radiomics Retinoblastoma

Journal

Scientific reports

ISSN: 2045-2322

Titre abrégé: Sci Rep

Pays: England

ID NLM: 101563288

Informations de publication

Date de publication:
23 10 2024

Historique:

received: 16 05 2024

accepted: 17 10 2024

medline: 24 10 2024

pubmed: 24 10 2024

entrez: 24 10 2024

Statut: epublish

Résumé

MYCN-amplified RB1 wild-type (MYCN

Identifiants

DOI: 10.1038/s41598-024-76933-6 PMID: 39443629

pubmed: 39443629

doi: 10.1038/s41598-024-76933-6

pii: 10.1038/s41598-024-76933-6

doi:

Substances chimiques

N-Myc Proto-Oncogene Protein 0

RB1 protein, human 0

MYCN protein, human 0

Retinoblastoma Binding Proteins 0

Ubiquitin-Protein Ligases EC 2.3.2.27

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

Pagination

25103

Informations de copyright

Références

Moll, A. C. et al. Incidence and survival of retinoblastoma in The Netherlands: a register based study 1862–1995. Br J Ophthalmol 81(7), 559–562 (1997).

doi: 10.1136/bjo.81.7.559 pubmed: 9290369 pmcid: 1722238

Pritchard, E. M., Dyer, M. A. & Guy, R. K. Progress in Small Molecule Therapeutics for the Treatment of Retinoblastoma. Mini Rev Med Chem 16(6), 430–454 (2016).

doi: 10.2174/1389557515666150722100610 pubmed: 26202204 pmcid: 5509337

Aubry, A., Yu, T. & Bremner, R. Preclinical studies reveal MLN4924 is a promising new retinoblastoma therapy. Cell Death Discov 6, 2 (2020).

doi: 10.1038/s41420-020-0237-8 pubmed: 32123578 pmcid: 7026052

Kooi, I. E. et al. Loss of photoreceptorness and gain of genomic alterations in retinoblastoma reveal tumor progression. Ebiomedicine 2(7), 660–670 (2015).

doi: 10.1016/j.ebiom.2015.06.022 pubmed: 26288838 pmcid: 4534696

Afshar, A. R. et al. Next-Generation Sequencing of Retinoblastoma Identifies Pathogenic Alterations beyond RB1 Inactivation That Correlate with Aggressive Histopathologic Features. Ophthalmology 127(6), 804–813 (2020).

doi: 10.1016/j.ophtha.2019.12.005 pubmed: 32139107

Schaiquevich, P. et al. Treatment of Retinoblastoma: What Is the Latest and What Is the Future. Front. Oncol. 12, 822330 (2022).

doi: 10.3389/fonc.2022.822330 pubmed: 35433448 pmcid: 9010858

Kapatai, G. et al. Gene expression profiling identifies different sub-types of retinoblastoma. Br J Cancer 109(2), 512–525 (2013).

doi: 10.1038/bjc.2013.283 pubmed: 23756868 pmcid: 3721394

Liu, J. et al. A high-risk retinoblastoma subtype with stemness features, dedifferentiated cone states and neuronal/ganglion cell gene expression. Nat Commun 12(1), 5578 (2021).

doi: 10.1038/s41467-021-25792-0 pubmed: 34552068 pmcid: 8458383

Rushlow, D. E. et al. Characterisation of retinoblastomas without RB1 mutations: genomic, gene expression, and clinical studies. Lancet Oncol 14(4), 327–334 (2013).

doi: 10.1016/S1470-2045(13)70045-7 pubmed: 23498719

Ewens, K. G. et al. Phosphorylation of pRb: mechanism for RB pathway inactivation in MYCN-amplified retinoblastoma. Cancer Med 6(3), 619–630 (2017).

doi: 10.1002/cam4.1010 pubmed: 28211617 pmcid: 5345671

Singh, H. P. et al. An immature, dedifferentiated, and lineage-deconstrained cone precursor origin of N-Myc-initiated retinoblastoma. Proc Natl Acad Sci U S A 119(28), e2200721119 (2022).

doi: 10.1073/pnas.2200721119 pubmed: 35867756 pmcid: 9282279

Price, E. A. et al. MYCN amplification levels in primary retinoblastoma tumors analyzed by Multiple Ligation-dependent Probe Amplification. Ophthalmic Genet 42(5), 604–611 (2021).

doi: 10.1080/13816810.2021.1923038 pubmed: 34003079

Lillington, D. M. et al. High level amplification of N-MYC is not associated with adverse histology or outcome in primary retinoblastoma tumours. Br J Cancer 87(7), 779–782 (2002).

doi: 10.1038/sj.bjc.6600532 pubmed: 12232763 pmcid: 2364265

Zugbi, S., et al., Clinical, Genomic, and Pharmacological Study of MYCN-Amplified RB1 Wild-Type Metastatic Retinoblastoma. Cancers, 2020. 12(9).

Abramson, D. H., Gobin, Y. P. & Francis, J. H. Orbital Retinoblastoma Treated with Intra-arterial Chemotherapy. Ophthalmology 128(10), 1437 (2021).

doi: 10.1016/j.ophtha.2021.03.018 pubmed: 34556310

Zhou, C., et al., Eye-Preserving Therapies for Advanced Retinoblastoma: A Multicenter Cohort of 1678 Patients in China. Ophthalmology, 2021.

Berry, J. L. et al. Genomic cfDNA Analysis of Aqueous Humor in Retinoblastoma Predicts Eye Salvage: The Surrogate Tumor Biopsy for Retinoblastoma. Molecular cancer research : MCR 16(11), 1701–1712 (2018).

doi: 10.1158/1541-7786.MCR-18-0369 pubmed: 30061186

De Jong, M. C. et al. Diagnostic Accuracy of Intraocular Tumor Size Measured with MR Imaging in the Prediction of Postlaminar Optic Nerve Invasion and Massive Choroidal Invasion of Retinoblastoma. Radiology 279(3), 817–826 (2016).

doi: 10.1148/radiol.2015151213 pubmed: 26690907

de Graaf, P. et al. Guidelines for imaging retinoblastoma: imaging principles and MRI standardization. Pediatr Radiol 42(1), 2–14 (2012).

doi: 10.1007/s00247-011-2201-5 pubmed: 21850471

de Jong, M. C. et al. Trilateral retinoblastoma: a systematic review and meta-analysis. Lancet Oncol 15(10), 1157–1167 (2014).

doi: 10.1016/S1470-2045(14)70336-5 pubmed: 25126964

Jansen, R. W. et al. MRI Features for Identifying MYCN-amplified RB1 Wild-type Retinoblastoma. Radiology 307(5), e222264 (2023).

doi: 10.1148/radiol.222264 pubmed: 37191489

Lambin, P. et al. Radiomics: the bridge between medical imaging and personalized medicine. Nature reviews Clinical oncology 14(12), 749–762 (2017).

doi: 10.1038/nrclinonc.2017.141 pubmed: 28975929

Strijbis, V. I. J. et al. Multi-view convolutional neural networks for automated ocular structure and tumor segmentation in retinoblastoma. Sci Rep 11(1), 14590 (2021).

doi: 10.1038/s41598-021-93905-2 pubmed: 34272413 pmcid: 8285489

Li, Z., et al., MRI-based radiomics model can improve the predictive performance of postlaminar optic nerve invasion in retinoblastoma. The British Journal of Radiology, 2022. 95(1130).

van Griethuysen, J. J. M. et al. Computational Radiomics System to Decode the Radiographic Phenotype. Cancer Res 77(21), e104–e107 (2017).

doi: 10.1158/0008-5472.CAN-17-0339 pubmed: 29092951 pmcid: 5672828

Cysouw, M. C. F. et al. Machine learning-based analysis of [(18)F]DCFPyL PET radiomics for risk stratification in primary prostate cancer. Eur J Nucl Med Mol Imaging 48(2), 340–349 (2021).

doi: 10.1007/s00259-020-04971-z pubmed: 32737518

Breiman, L. Random Forests. Machine Learning 45, 5–32 (2001).

doi: 10.1023/A:1010933404324

Murphy, A.H., A New Vector Partition of the Probability Score. Journal of Applied Meteorology and Climatology, 1973. 12(4).

Lundberg, S.M. and S.-I. Lee, A unified approach to interpreting model predictions. Advances in neural information processing systems, 2017. 30.

Ojala, M. and G.C. Garriga, Permutation tests for studying classifier performance. Journal of machine learning research, 2010. 11(6).

Xu, L., et al., Establishing the Clinical Utility of ctDNA Analysis for Diagnosis, Prognosis, and Treatment Monitoring of Retinoblastoma: The Aqueous Humor Liquid Biopsy. Cancers (Basel), 2021. 13(6).

Yuan, W. et al. Temporal bias in case-control design: preventing reliable predictions of the future. Nat Commun 12(1), 1107 (2021).

doi: 10.1038/s41467-021-21390-2 pubmed: 33597541 pmcid: 7889612